The hidden connection: how your microbiome impacts fertility
The communities of bacteria that inhabit the vagina, uterus, gut, and semen play an important role in fertility. Could targeting microbiota with therapies such as probiotics improve the chances of success of assisted reproductive technologies (ART)?
- Learn all about microbiota
- Microbiota and related conditions
- Act on your microbiota
- Publications
- About the Institute
Healthcare professionals section
Find here your dedicated sectionSources
This article is based on scientific information
About this article
Infertility affects approximately 1 in 10 couples. But a new discovery 1 could bring them hope: the tiny bacteria that live in our bodies may play a key role in our ability to conceive. These communities interact with our immune system, our hormones, and our metabolism.
12 Infertility is generally defined as the failure of a couple of reproductive age to achieve pregnancy after 12 months of regular unprotected intercourse ¹.
8-12% Infertility affects an estimated 8–12% of couples worldwide, making it a major reproductive health issue ¹.
For women and men: a matter of balance
In women, a healthy vaginal microbiota is dominated by beneficial bacteria called Lactobacillus, particularly the species L. crispatus. These bacteria are allies of our intimate health by maintaining an acidic environment, limiting inflammation, and promoting the uterus’s receptivity to pregnancy. When this balance is disrupted (vaginal dysbiosis), other bacteria associated with an imbalance become more abundant: the vaginal pH rises, inflammation increases, potentially impairing sperm motility, embryo implantation and immune tolerance between the mother and the fetus.
The uterus is also believed to have its own microbiota. The presence of beneficial bacteria in the endometrium is thought to improve pregnancy rates, while certain pathogens are thought to reduce them. However, these findings remain controversial, because the samples are difficult to analyze and are highly susceptible to contamination.
In men, semen also contains its own microbiota. When beneficial bacteria dominate, they produce fewer inflammatory compounds and protect spermatic DNA. Conversely, certain pathogenic bacteria may increase inflammation and slow sperm motility. However, studies linking seminal microbiota to male fertility are still limited and require further research.
The gut: the hidden conductor?
The gut microbiota may also influence fertility through the immune system, hormones, and metabolism. In women with polyendocrine ovarian metabolic syndrome (formerly polycystic ovary syndrome), an imbalance in the gut microbiota seems to promote inflammation, insulin resistance, and hormonal disruptions. Another example is endometriosis, a condition associated with gut dysbiosis that may also alter estrogen metabolism, enhance inflammation, and contribute to the growth of lesions which could potentially affect the embryo’s ability to implant in the uterus.
Polyendocrine ovarian metabolic syndrome (formerly polycystic ovary syndrome)
Polycystic ovary syndrome was renamed polyendocrine ovarian metabolic syndrome (POMS) in May 2026. It is a condition associated with hormonal and metabolic imbalances that affects 1 in 8 women.
Most symptoms of POMS appear early, often during puberty, they include:
- excessive testosterone production, which manifests notably as excessive hair growth in 70% of affected women ;
- acne, and hair loss ;
- ovulatory disorders ;
- and polycystic ovaries.
The persistent hormonal imbalance leads to the development of multiple small follicles as well as irregular menstrual cycles, which can ultimately lead to infertility in women 2.
How can balance be restored?
As a preventive measure, it is important to avoid any practices that may disrupt your vaginal or seminal microbiota and your gut microbiota. In the event of a confirmed bacterial infection (vaginosis), your doctor may prescribe appropriate treatment.
Approaches aimed at modulating microbiota to restore balance – such as probiotics – are also being investigated, but their impact on pregnancy outcomes remain uncertain. As for microbiota transplantations, they are still limited to clinical research. In the future, microbiota profiling could help better personalize care for couples undergoing assisted reproductive technology (ART) cycles. However, this approach remains under evaluation and requires more robust scientific evidence before it can be incorporated into standard clinical practice.
Practices that put your vaginal microbiota at risk
1.Du B, Yang Y, He L, Tang Y. Microbiota and infertility: a translational review of mechanisms and clinical applications in assisted reproduction. Eur J Obstet Gynecol Reprod Biol. 2026 Feb 20;318:114941. doi: 10.1016/j.ejogrb.2026.114941.
2.Teede HJ, Khomami MB, Morman R et al. Global Name Change Consortium. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026 Jun 6;407(10545):2329-2339. doi: 10.1016/S0140-6736(26)00717-8.
See also